Rep. Chris Collins (R-N.Y.), President Trump’s first congressional supporter, was charged with insider trading related to his position on the board of Australian biotechnology company Innate Immunotherapeutics. On June 22, 2017, while attending a Congressional Picnic at the White House, …
Chris CollinsCameron CollinsStephen ZarskyInnate Immunotherapeuticscongressional-corruptioninsider-tradingprosecutionsregulatory-capture
On August 31, 2016, Rep. Tom Price (R-GA), chairman of the House Budget Committee and member of the Ways and Means Health Subcommittee, purchased between $50,001 and $100,000 in discounted shares of Innate Immunotherapeutics, an Australian biotech company, through a private placement offering …
Tom PriceChris CollinsInnate ImmunotherapeuticsZimmer BiometHouse Energy and Commerce Committeeinsider-tradingcongressional-corruptionhealthcarerevolving-doorstock-act-violation+2 more